Stem Cell Therapy and Nanotechnology in Diabetes

A successful bone marrow or stem cell transplant may help slow or halt the progression of certain metabolic syndromes including type 1 diabetes, but early diagnosis is critical to prevent irreversible disease progression. Pancreatic islet allotransplantation is a procedure in which islets from the donor pancreas are transferred into another person to treat type 1 diabetes and have been a promising cellular-based therapy. The recent advances in nanomedicine include smart drugs which only activate when needed, nanoformulations for efficient drug delivery, engineered microbes which produce human hormones, and even nanorobots, which would move autonomously around the body acting as a boost, for our immune system, red blood cells, or many other biological systems.

  • Islet Cell Transplantation
  • Embryonic Stem Cells
  • Mesenchymal Stem Cell Therapy

Related Conference of Stem Cell Therapy and Nanotechnology in Diabetes

March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands
May 14-15, 2026

7th World Summit on Diabetes

Rome, Italy
May 18-19, 2026

57th Annual Congress on Endocrinology and Diabetes Research

Aix-en-Provence, France
June 22-23, 2026

16th World Congress on Endocrinology and Diabetes

Paris, France
August 17-18, 2026

4th World congress and Expo on Diabetes

Toronto, Canada
September 29-30, 2026

22nd World Congress on Endocrinology & Diabetes

Paris, France

Stem Cell Therapy and Nanotechnology in Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in